Ondansetron versus magnesium infraclavicular brachial plexus block

Ondansetron versus magnesium sulphate as adjuvants to ultrasound guided infraclavicular brachial plexus block in patients undergoing hand and forearm surgery

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

PACTR

Registry ID

PACTR201608001747141

Enrollment

Registered

2016-08-20

Start date

2016-06-01

Completion date

Unknown

Last updated

2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery anesthesia and postoperative pain Orthopaedics Anaesthesia

Interventions

control group(C):

: Ondansetron group (O)

Magnesium sulphate group (M)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: age 18 ¿ 60 years of either gender ASA I-II undergoing elective hand and forearm surgery

Exclusion criteria

Exclusion criteria: Patients with significant neurological, psychiatric, neuromuscular, cardiovascular, pulmonary, renal or hepatic diseases allergy to study drugs pregnant or lactating women morbid obesity coagulation disorders

Design outcomes

Primary

Measure	Time frame
The onset of sensory and motor block ;duration of sensory and motor block;VAS score	—

Secondary

Measure	Time frame
total consumption of rescue analgesia;patient satisfaction ;any intra or postoperative complications such as pneumothorax, hematoma, nausea, vomiting , respiratory depression , bradycardia or hypotension., sedation	—

Countries

Egypt

Contacts

Public ContactShaimaa Farouk

Lecturer of anesthesia and ICU

Shaimaafarouk7777@yahoo.com01270440771

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Sep 19, 2026